Heparin Dosing During Percutaneous Coronary Intervention and Obesity.
Kreutz RP, Leon IG, Bain ER, George B, Phookan S, Prakash A, Sinha AK, Breall JA, Zenisek JR, Frick KA, Jaradat ZA, Abu Romeh IS, O'Leary B, Kalra A, Kumar A, Lee MS, von der Lohe E.
Kreutz RP, et al. Among authors: breall ja.
J Cardiovasc Pharmacol. 2024 Mar 1;83(3):251-257. doi: 10.1097/FJC.0000000000001525.
J Cardiovasc Pharmacol. 2024.
PMID: 38086077